Guangdong Second Provincial General Hospital
Clinical trials sponsored by Guangdong Second Provincial General Hospital, explained in plain language.
-
New combo aims to stop AML from coming back
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding venetoclax to standard chemotherapy can help keep acute myeloid leukemia (AML) from returning. It is for adults aged 18 to 65 who are already in remission after initial treatment. The goal is to see if the combination leads to fewer cancer cells le…
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated May 16, 2026 11:20 UTC
-
New drug cocktail shows promise for Tough-to-Treat leukemia
Disease control ENROLLING_BY_INVITATIONThis study tests a combination of three drugs (homoharringtonine, venetoclax, and azacitidine) in 40 adults newly diagnosed with a rare, aggressive leukemia called MPAL. The goal is to see if the combo can safely achieve remission. This is not a cure—patients may need further tre…
Phase: PHASE2 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC